The percentage of tumors with PD‐L1 TC2/3 and/or IC2/3 status (PD‐L1 expression on ≥5% of tumor cells [TC] and/or IC, respectively) was slightly lower in tTMB‐low patients than in tTMB‐high patients (18.2% and 40.8% vs 25.7% and 47.4%, respectively). The gene discussed is CD274; the disease is neoplasm.